Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02284685 · ClinicalTrials.gov registry record · Phase 1
A Novel Intervention Promoting Eating Disorder Treatment Among College Students
A Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 1
- Development phase
- 1,149
- Enrollment target
NCT02284685: Completed Phase 1 study, sponsored by University of Michigan.
NCT02284685 is a Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 1,149 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1815% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02284685, a Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1,149 participants
- Enrollment target
Study Summary
Eating disorders (EDs) have the highest rate of mortality of any mental illness. On U.S. college campuses, an estimated 80% students with clinically significant ED symptoms do not receive treatment. There are likely more than one million students whose EDs go untreated in any given year. Left untreated EDs typically become more severe and refractory to treatment. Given the impact of EDs on mental and physical health and the connection therein with social, academic, and economic outcomes, an effective intervention to increase rates of treatment utilization would have broad societal effects extending well beyond the campus setting. This study is an online intervention designed to identify and increase help-seeking among undergraduates with previously undiagnosed/untreated EDs.
Primary Outcome
Use of services (e.g., counseling/therapy) for eating and body image issues
Interventions
- BEHAVIORAL Promoting Eating Disorder Treatment among College Students
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,149 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-05 |
| Phase | Phase 1 |
What the finished NCT02284685 record still lists
NCT02284685 is an interventional study that assigns participants to a tested intervention. Its 1,149 participants enrollment target places it among the larger protocols in the corpus, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1815% higher).
The record links to 0 conditions, and to 1 intervention - of which Promoting Eating Disorder Treatment among College Students is the first listed.
NCT02284685 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02284685 about?
NCT02284685 is a clinical study titled "A Novel Intervention Promoting Eating Disorder Treatment Among College Students". Eating disorders (EDs) have the highest rate of mortality of any mental illness. On U.S. college campuses, an estimated 80% students with clinically significant ED symptoms do not receive treatment. There are likely more than one million students whose EDs go untreated in any given year. Left untrea...
What is the current status of trial NCT02284685?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1,149 participants. The study started on 2015-01. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02284685?
The interventions under investigation include: Promoting Eating Disorder Treatment among College Students (BEHAVIORAL).
Who is sponsoring clinical trial NCT02284685?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02284685's enrollment target sits among peer trials
1,149 5th of 2000 higher than 1,996 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06408181 · 1,150 participants · Phase 3
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
- NCT06528314 · 1,150 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- NCT07293559 · 1,150 participants
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
- NCT07339423 · 1,150 participants · Phase 3
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia